Similarly, a recent study of an M2-like macrophage marker showed that increasing CD163+ immune cells were also associated with pronounced improvement in overall survival in TNBC, even though this marker is generally regarded as signifying a pro-tumor microenvironment. Here, CD163 is linked to neoplasm.